semaglutide fda approved Approves Oral for Weight Loss FDA Approves Semaglutide for New

Clinician discretion still applies based on intake history

One literature review published in JAMA in April 2025 by a group of Irish researchers stated that GLP-1 drugs are known to reduce inflammation, improve insulin signaling, and promote neurogenesis, all of which could protect against cognitive decline. These potential benefits could also have an effect on cancer outcomes

References Mahapatra MK, et al

This customized compounded formulation offers patients an approach that can be better tolerated and more effective than standard brand-name versions

Constipation Slow transit may prolong intestinal contact with biliary metabolites and increase the opportunity for deconjugation and reabsorption

Constipation: In some cases, this can lead to more severe intestinal blockages or fecal impaction